Self-pay options, available through Novo Nordisks pharmacy and select telehealth providers, are expected to range from approximately $149 to $299 per month, depending on dose strength, defining a months supply as one bottle of 30 pills
Potential exceptions exist when the prescriber can show a patient has a medical need for a formulation significantly different from the commercial product, for example, an allergy to an inactive ingredient in the approved drug
This comes from the FDA prescribing information, which sets "more than 2 days" as the boundary, and from Novo Nordisk's patient FAQ: "as long as your last dose of Wegovy was given 2 or more days before." Tirzepatide products (Mounjaro and Zepbound) use a different 72-hour minimum
#BreakingNews #Healthcare #Biotech #Pharma #GLP1 #NovoNordisk #WeightLoss #Markets #WallStreet #FinancialMarkets To view or add a comment, sign in Obesity pill gets huge head start on Eli Lilly
All data from those monkeys were excluded from the averages unless otherwise noted
